摘要
心力衰竭(HF)的发生发展涉及复杂的病理生理学机制间的相互作用,包括炎症,组织重构,神经激素和内分泌,以及肾脏和交感神经等。随着对HF机制探索的不断深入,人们对HF的生物标记物的认识也更趋全面。本文简要介绍一些在此过程中发现的新的生物标记物,如ST2,半乳糖凝集素-3,半胱氨酸蛋白酶抑制剂C等,并对其临床价值做一综述。
： The development of heart failure （HF） involves an interplay of muhiple pathophysiological mechanisms including inflammation, tissue remodeling, neurohormonal and endocrine signaling, and interactions with the renal and nervous systems. Understanding of the biomarkers in HF is more comprehensive now as a result of the furthering of the exploration of the HF mechanism. In this paper we will briefly review some new biomarkers such as ST2, galectin-3 and cystatin C and their clinical values.
出处
《心脏杂志》
CAS
2014年第4期484-486,490,共4页
Chinese Heart Journal
